Markus Niggli

1.7k citations
26 papers · 1.2k · 1 hit paper · h-index 13

Impact in

  • Hematology top 1%
    • Hemophilia Treatment and Research
    • Platelet Disorders and Treatments
    • Blood Coagulation and Thrombosis Mechanisms
    • Hemostasis and retained surgical items
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 10%
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema

Papers in

    • Hemophilia Treatment and Research 19
    • Platelet Disorders and Treatments 4
    • Chronic Myeloid Leukemia Treatments 2
    • Blood Coagulation and Thrombosis Mechanisms 1
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 5
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema 1

Markus Niggli

25 papers receiving 1.2k citations

Markus Niggli's Hit Papers

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors 2018 · 522 citations
5220+2+5Years since publication100200300400500

Peers

Markus Niggli
Comparison fields: 5 of 65
  • Hematology 920
  • Genetics 119
  • Endocrinology, Diabetes and Metabolism 161
  • Biological Psychiatry 23
  • Pharmacology 47
Replace Jonathan M. Flanagan with:
Jonathan M. Flanagan United States
Sabine Haxelmans Germany
Tomoko Saito Japan
Ali Awsat Mellati Iran
Povl Nilsson Denmark
Jana Ernst Germany
María Ofelia Barber Fox Cuba
N. Barbot France
Jette Nowak Denmark
Donatas Stakišaitis Lithuania
Markus Niggli relative to Jonathan M. Flanagan United States Jonathan M. Flanagan's profile →
Citations per field
00.5×10×15×20×23×
Jonathan M. Flanagan · 1×
Citations per year

Countries citing papers authored by Markus Niggli

Since Specialization
Citations

This map shows the geographic impact of Markus Niggli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Niggli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Niggli more than expected).

Fields of papers citing papers by Markus Niggli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Niggli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Niggli. The network helps show where Markus Niggli may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Niggli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Niggli Line = papers co-authored together Markus Niggli links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
Hit paper breakdown →
2018522
2 2020180
3 2008144
4 200949
5 202146
6 202338
7 202136
8 202233
9 202031
10 202226
11 201922
12 202114
13 202214
14 20249
15
Rapport de synthèse réalisé dans le cadre du projet CONSECRU 2 Estimation des débits de crue du Rhône à Porte du Scex et autres points amont caractéristiques
20068
16 20158
17 20196
18 20195
19 20185
20 20164

About Markus Niggli

Markus Niggli is a scholar working on Hematology, Genetics, Endocrinology, Diabetes and Metabolism, Hepatology and Pharmacology, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Platelet Disorders and Treatments (4 papers), Diabetes Treatment and Management (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Hepatitis C virus research (2 papers), Blood Coagulation and Thrombosis Mechanisms (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Hematology (920 citations), Genetics (119 citations), Endocrinology, Diabetes and Metabolism (161 citations), Biological Psychiatry (23 citations) and Pharmacology (47 citations). Markus Niggli has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Ido Paz‐Priel, Christophe Schmitt, Víctor Jiménez‐Yuste, Johannes Oldenburg, Gallia G. Levy, Johnny Mahlangu, Maria Elisa Mancuso, Michael U. Callaghan, Midori Shima and Rebecca Kruse‐Jarres. Their work appears in journals such as Blood, Haemophilia, Diabetes Obesity and Metabolism, Research and Practice in Thrombosis and Haemostasis and Diabetic Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact